HALISTER: Zeltiq to Be Bought by Allergan for $2.47b, or $56.50-Share

Zeltiq to Be Bought by Allergan for $2.47b, or $56.50-Share

(Bloomberg) -- Zeltiq to be bought by Allergan for $56.50-share cash, or 14% premium to Feb. 10 close.
  • Allergan sees deal immediately accretive, will host call 9am
  • ZLTQ halted
To contact the reporter on this story: Arie Shapira in New York at ashapira3@bloomberg.net
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
AGN US (Allergan PLC)
ZLTQ US (Zeltiq Aesthetics Inc)

To de-activate this alert, click here

UUID: 7947283